Cargando…

Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program

The Cancer Immunotherapy Immunoguiding Program has conducted an IFN-γ ELISPOT proficiency panel to examine the influence of serum supplementation of test media on assay performance. Sixteen European laboratories analyzed the same PBMC samples using different locally established protocols. Participan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mander, A., Gouttefangeas, C., Ottensmeier, C., Welters, M. J. P., Low, L., van der Burg, S. H., Britten, C. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813523/ https://www.ncbi.nlm.nih.gov/pubmed/20052465 http://dx.doi.org/10.1007/s00262-009-0814-4

Ejemplares similares

Response definition criteria for ELISPOT assays revisited
por: Moodie, Z., et al.
Publicado: (2010)

Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells
por: Janetzki, Sylvia, et al.
Publicado: (2009)

Report on the Fifth Annual Meeting of the Association for Immunotherapy of Cancer (CIMT) April 12–14, 2007 in Würzburg, Germany
por: Welters, Marij J. P., et al.
Publicado: (2007)

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8(+) T lymphocytes by structural and functional assays
por: Britten, C. M., et al.
Publicado: (2007)

Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols
por: Filbert, Helene, et al.
Publicado: (2012)

Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8(+) T cells with detection by ELISPOT and HLA-multimer staining
por: Chudley, Lindsey, et al.
Publicado: (2014)

Harmonization of the intracellular cytokine staining assay
por: Welters, Marij J. P., et al.
Publicado: (2012)

Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides
por: Maecker, Holden T, et al.
Publicado: (2008)

Comparison of SARS-CoV-2- and HCoV-Specific T Cell Response Using IFN-γ ELISpot
por: Thümmler, Laura, et al.
Publicado: (2021)

Reversion and conversion of Mycobacterium tuberculosis IFN-γ ELISpot results during anti-tuberculous treatment in HIV-infected children
por: Connell, Tom G, et al.
Publicado: (2010)

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
por: Mandruzzato, Susanna, et al.
Publicado: (2016)

Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis
por: Chiappini, Elena, et al.
Publicado: (2012)

Improvement of IFNγ ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis
por: Santos, Radleigh, et al.
Publicado: (2014)

Pretransplant Donor-specific IFNγ ELISPOT as a Predictor of Graft Rejection: A Diagnostic Test Accuracy Meta-analysis
por: Montero, Nuria, et al.
Publicado: (2019)

An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity
por: Barabas, Sascha, et al.
Publicado: (2017)

CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy
por: Kranz, Lena M., et al.
Publicado: (2017)

Determining the Latent Tuberculosis Infection by IFN - γ Elispot Assay in Healthcare Workers From University Hospitals of Shiraz, South West of Iran
por: Taheri, Mohammad, et al.
Publicado: (2013)

Monitoring cell-mediated immune responses in AAV gene therapy clinical trials using a validated IFN-γ ELISpot method
por: Patton, Kathryn S., et al.
Publicado: (2021)

Comparative Multi-Donor Study of IFNγ Secretion and Expression by Human PBMCs Using ELISPOT Side-by-Side with ELISA and Flow Cytometry Assays
por: Hagen, Jodi, et al.
Publicado: (2015)

IFN-γ-Based ELISpot as a New Tool to Detect Human Infections with Borna Disease Virus 1 (BoDV-1): A Pilot Study
por: Eidenschink, Lisa, et al.
Publicado: (2023)

Toward the harmonization of immune monitoring in clinical trials: Quo vadis?
por: Britten, C. M., et al.
Publicado: (2007)

The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study
por: Singh, Satwinder Kaur, et al.
Publicado: (2012)

Increased Level of IFN-γ and IL-4 Spot-Forming Cells on ELISPOT Assay as Biomarkers for Acute Graft-Versus-Host Disease and Concurrent Infections
por: Hirayama, Masahiro, et al.
Publicado: (2012)

Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation
por: Wagner-Drouet, Eva, et al.
Publicado: (2021)

Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium
por: Waerlop, Gwenn, et al.
Publicado: (2022)

Modified ELISPOT: Modifications of the Elispot Assay for T Cell Monitoring in Cancer Vaccine Trials
por: Malyguine, Anatoli
Publicado: (2005)

A framework for T cell assays
por: Britten, Cedrik M., et al.
Publicado: (2015)

Mobilization permits reliable ELISPOT detection of long-term memory T cells secreting IFN-γ, IL-4, IL-5, and IL-17 without in vitro expansion
por: Ghosh, Jaya, et al.
Publicado: (2013)

Detection of natural infection with Mycobacterium intracellulare in healthy wild-caught Chacma baboons (Papio ursinus) by ESAT-6 and CFP-10 IFN-γ ELISPOT tests following a tuberculosis outbreak
por: Chege, Gerald K, et al.
Publicado: (2008)

FLU-v, a Broad-Spectrum Influenza Vaccine, Induces Cross-Reactive Cellular Immune Responses in Humans Measured by Dual IFN-γ and Granzyme B ELISpot Assay
por: Oftung, Fredrik, et al.
Publicado: (2022)

CIMT 2023: report on the 20th Annual Meeting of the Association for Cancer Immunotherapy
por: Dallmann, J., et al.
Publicado: (2023)

Validation of an IFN-gamma ELISpot assay to measure cellular immune responses against viral antigens in non-human primates
por: Yang, Fan, et al.
Publicado: (2021)

Constraint-Induced Movement Therapy (CIMT): Current Perspectives and Future Directions
por: Reiss, Aimee P., et al.
Publicado: (2012)

Time-related trends in variability of cIMT changes in statin trials
por: Davidson, Michael H., et al.
Publicado: (2015)

Encoder-Decoder Architecture for Ultrasound IMC Segmentation and cIMT Measurement
por: Al-Mohannadi, Aisha, et al.
Publicado: (2021)

Longitudinal Assessment of an ELISPOT Test for Mycobacterium tuberculosis Infection
por: Hill, Philip C, et al.
Publicado: (2007)

Nickel, palladium and rhodium induced IFN-gamma and IL-10 production as assessed by in vitro ELISpot-analysis in contact dermatitis patients
por: Bordignon, Valentina, et al.
Publicado: (2008)

Hierarchical Modeling for Rare Event Detection and Cell Subset Alignment across Flow Cytometry Samples
por: Cron, Andrew, et al.
Publicado: (2013)

Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT
por: Maecker, Holden T, et al.
Publicado: (2005)

Managing Multi-center Flow Cytometry Data for Immune Monitoring
por: White, Scott, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d7bfq5a8mojjckvgq9j5osdh2m